AFT Pharmaceuticals announced an agreement with Hainan Haiyao Co. Ltd. to distribute Crystaderm® cream in China, the second largest pharma market in the world. Crystaderm cream is a proprietary product that treats skin infections by the slow release of hydrogen peroxide onto the skin as an alternative to topical antibiotics, which if misused risk development of drug resistant bacteria.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 NZD | -0.66% |
|
+4.48% | -13.43% |
07-09 | New Zealand Shares Jump on US Rate Cut Optimism; AFT Pharmaceuticals to Launch Topical Medication in China | MT |
07-09 | AFT Pharmaceuticals to Launch Skin Infection Cream in China | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
3.03 NZD | -0.66% | +4.48% | 194M | ||
2.93 CNY | -1.68% | -2.66% | 524M | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.43% | 194M | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals Announces an Agreement with Hainan Haiyao Co. Ltd to Distribute Crystaderm® Cream in China